These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 13570906)

  • 1. The role of the marrow in prothrombin and proconvertin synthesis.
    GORDIN R
    Acta Haematol; 1958 Jun; 19(6):341-6. PubMed ID: 13570906
    [No Abstract]   [Full Text] [Related]  

  • 2. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 4. The activity of plasma prothrombin and proconvertin in acute cholecystitis.
    AROSENIUS KE; SJOSTROM B
    Acta Soc Med Ups; 1960; 65():16-9. PubMed ID: 13794485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma prothrombin-proconvertin content following therapeutic doses of heparin].
    MUNCK O
    Ugeskr Laeger; 1956 Jan; 118(2):38-9. PubMed ID: 13312131
    [No Abstract]   [Full Text] [Related]  

  • 6. Micromethod for quantitative determination of plasma prothrombin and proconvertin.
    DYGGVE H; LUND E
    Acta Med Scand; 1954; 150(3):207-14. PubMed ID: 13206681
    [No Abstract]   [Full Text] [Related]  

  • 7. Prothrombin and proconvertin in the newborn and during the first year of life.
    DYGGVE H
    Acta Paediatr (Stockh); 1958 May; 47(3):251-9. PubMed ID: 13532682
    [No Abstract]   [Full Text] [Related]  

  • 8. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of prothrombin and proconvertin (SPCA); concentrations in plasma of patients with pernicious anemia in remission, treated with vitamin B12.
    VETNE G; AXELROD AR
    Am J Clin Pathol; 1954 Jul; 24(7):796-801. PubMed ID: 13171349
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of oral and intravenous administration of vitamins K on the prothrombin and proconvertin levels of cholecystnephrostomized dogs.
    FISHER LM; JAQUES LB; MILLAR GJ
    Can J Biochem Physiol; 1956 Sep; 34(5):1039-51. PubMed ID: 13364731
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of coagulation time obtained with the one-stage method according to Quick (prothrombin time) and according to Owren (prothrombin-proconvertin time) in the control of coumarin treatment].
    CLETON FJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1835-6. PubMed ID: 13810671
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin].
    SOULIER JP; LARRIEU MJ
    Sang; 1952; 23(7):549-59. PubMed ID: 13004906
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial purification of human prothrombin and proconvertin: their characteristics and interaction.
    LEWIS JH; FERGUSON JH
    J Clin Invest; 1953 Oct; 32(10):915-21. PubMed ID: 13096556
    [No Abstract]   [Full Text] [Related]  

  • 19. [Owren's method for quantitative prothrombin-proconvertin determination in control of anticoagulant therapy].
    LUND E
    Ugeskr Laeger; 1953 May; 115(21):801-5. PubMed ID: 13077997
    [No Abstract]   [Full Text] [Related]  

  • 20. [The behavior of prothrombin, of factor V and of factor VII before and after exchange transfusion].
    FELICI W
    Minerva Pediatr; 1959 Jul; 11():756-61. PubMed ID: 13822081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.